CACNA1D and cancer: CaV1.3 is a member of the L‐type VGCC family, and in recent years, more and more studies have shown that CaV1.3 is associated with cancer development, and CaV1.3 is a potential therapeutic target and prognostic biomarker for cancer therapy.